Actome has a total of 30 patents globally, out of which 1568 have been granted. Of these 30 patents, more than 93% patents are active. United States of America is where Actome has filed the maximum number of patents, followed by Europe (EPO) and Singapore. Parallelly, Germany seems to be
NR SOOS Technology has a total of 27 patents globally, out of which 12 have been granted. Of these 27 patents, more than 88% patents are active. United States of America is where NR SOOS Technology has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and China.
Arsenal Biosciences has a total of 65 patents globally, out of which 2 have been granted. Of these 65 patents, more than 89% patents are active. United States Of America is where Arsenal Biosciences has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States Of
Yunnan Botanee Bio-Tech has a total of 279 patents globally, out of which 182 have been granted. Of these 279 patents, more than 86% patents are active. China is where Yunnan Botanee Bio-Tech has filed all their patents. Parallelly, China seems to be the main focused R&D centre and also
Seneca Therapeutics has a total of 31 patents globally. Of these 31 patents, more than 90% patents are active. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Seneca Therapeutics. Seneca Therapeutics was founded in the year 2018. Seneca
RNAissance has a total of 88 patents globally, out of which 34 have been granted. Of these 88 patents, more than 78% patents are active. The United States of America is where RNAissance has filed the maximum number of patents, followed by Europe (EPO) and Australia. Parallelly, The United States
RNAimmune has a total of 31 patents globally. Of these 31 patents, more than 87% patents are active. The United States of America is where RNAimmune has filed the maximum number of patents, followed by Singapore and China. Parallelly, The United States of America seems to be the main focused
Scout Bio has a total of 32 patents globally. Of these 32 patents, more than 87% patents are active. Parallelly, The United States of America seems to be the main focused R&D center and also the origin country of Scout Bio. Scout Bio is subpart of Ceva Animal Health was
C4 Therapeutics has a total of 273 patents globally, out of which 18 have been granted. Of these 273 patents, more than 83% patents are active. United States of America is where C4 Therapeutics has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United States
Cathay Biotech has a total of 142 patents globally, out of which 64 have been granted. Of these 142 patents, more than 80% patents are active. United States of America is where Cathay Biotech has filed the maximum number of patents, followed by Europe and Germany. Parallelly, China seems to
Interested in in-depth patent data and patent portfolio analysis of Tesla. Get your report now.